Mizuho Securities USA’s ResMed RMD Stock Holding History

Mizuho Securities USA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	11,356 +2,549	+29%	+$528K	0.04%	411
2026 Q1	$1.98M	Sell	8,807 -1,821	-17%	-$454K	0.05%	386
2025 Q4	$2.72M	Sell	10,628 -36	-0.3%	-$9.21K	0.04%	348
2025 Q3	$2.93M	Buy	10,664 +526	+5%	+$144K	0.06%	319
2025 Q2	$2.62M	Sell	10,138 -1,622	-14%	-$387K	0.06%	329
2025 Q1	$2.63M	Sell	11,760 -2,153	-15%	-$503K	0.06%	329
2024 Q4	$3.18M	Buy	13,913 +4,385	+46%	+$1.06M	0.06%	309
2024 Q3	$2.33M	Sell	9,528 -1,803	-16%	-$403K	0.05%	323
2024 Q2	$2.17M	Buy	+11,331	New	+$2.3M	0.05%	352

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mizuho Securities USA's RMD Position: Q2 2026 in Review

Mizuho Securities USA increased its ResMed (RMD) stake by 29% in Q2 2026, buying an estimated $528K and bringing the position to 11,356 shares worth $2.21M. The position accounts for 0.04% of the portfolio, ranked #411.

Mizuho Securities USA first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.18M in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Mizuho Securities USA held 11,356 shares of ResMed worth $2.21M as of Q2 2026.
Mizuho Securities USA bought 2,549 ResMed shares in Q2 2026, an estimated $528K.
ResMed made up 0.04% of Mizuho Securities USA's portfolio in Q2 2026, its #411 holding.
Mizuho Securities USA first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Mizuho Securities USA's ResMed position peaked at $3.18M in Q4 2024.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.